Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Posts Basic Consolidated EPS Of $-1.0036

0

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)managed to report annual basic consolidated EPS of $-1.0036, which was for the year ended2015-12-31.The company reported basic consolidated EPS of $-1.0036 for the quarter ended 2015-12-31.

EPS from continuing operations

If you look at the performance of the company’s continuing operations, you see that EPS generated from such operations was {EPS_BASIC_CONT_OPER:1541}} for the year ended 2015-12-31. As for the quarter ended 2015-12-31, continuing operations produced EPS of $-0.15.

EPS contribution from parent

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) received of $-1.0036 EPS boost from the parent company for the annual period ended

For the year ended 2015-12-31, the parent of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) contributed EPS of $-1.0036 to the company’s bottom-line. But for the quarter ended 2015-12-31, EPS boost from the parent was cited as $-1.0036.

What About Basic net EPS

The basic net EPS that Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) reported for the year ended 2015-12-31 stood at $-1. For the quarter ended 2015-12-31, the company posted basic net EPS of $-1.

What About Consolidated Diluted EPS?

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)’s consolidated diluted EPS for the year ended 2015-12-31 was reported as $-1.0036. For the quarter ended 2015-12-31 the metric was$-1.0036.

Basic diluted EPS

The company managed to register diluted EPS from continuing operation of at $-1.0036 for the yearended 2015-12-31. But diluted EPS from continuing operations for the quarter ended 2015-12-31 came in at $-1.0036.

Net diluted EPS

Net diluted EPS posted by Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) for the year ended 2015-12-31 was $-1. On quarterly basis, net diluted EPS for the quarter ended 2015-12-31 was reported as $-1.

What portion of diluted EPS came from parent?

For the annual period ended 2015-12-31, the parent company of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) said that it parent company boosted its diluted EPS by$-1.0036 in the year ended 2015-12-31. For the quarter ended 2015-12-31, the parent company’s contribution to diluted EPS was $-1.0036.

The company reported net basic EPS of $-1 for the year ended 2015-12-31 and net basic EPS of $-1 for the quarter ended 2015-12-31.

The number of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)’s basic shares outstanding at the end of the annual period ended 2015-12-31 was 142.155. That compares with 142.155 basic shares outstanding for the quarter ended 2015-12-31.

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) had 142.155 diluted shares outstanding at the end of the annual period ended 2015-12-31. But for the quarter ended 2015-12-31, diluted outstanding shares were 142.155.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 13 times, 1 visits today)